Law360 (July 10, 2019, 6:00 PM EDT) -- The normally mundane process of admitting outside attorneys to participate in specific litigation in a jurisdiction to which they are not admitted got complicated for a prominent antitrust plaintiff's bar attorney who initially failed to report years-old disciplinary actions in his application to participate in a New Jersey case.
A New Jersey federal magistrate judge assigned to a pay-for-delay lawsuit against Pfizer and Ranbaxy over the blockbuster cholesterol therapy Lipitor on Tuesday vacated the late June pro hac vice admission of Joseph M. Alioto after the California-based lawyer informed the court that he wrongly claimed to have never faced disciplinary action....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!